What Is the iFuse Procedure for SI Joint Pain?

The iFuse procedure is a minimally invasive surgery that fuses the sacroiliac (SI) joint using a series of triangular titanium implants driven across the joint from the side of the pelvis. In randomized trials, patients who underwent this procedure saw pain scores drop by roughly 50 to 55 points on a 100-point scale at six months, compared with drops of only 5 to 12 points for those managed without surgery. The procedure takes less than an hour, typically requires only a small incision, and has a complication profile that compares favorably to open SI joint surgery. Understanding who benefits, what the recovery looks like, and what the evidence actually shows at five years and beyond gives a much fuller picture than the basic description alone.

Why the Sacroiliac Joint Becomes a Pain Source

The sacroiliac joint sits where the base of the spine meets the pelvis, transferring load between the upper body and legs with every step. Despite its limited range of motion, the joint absorbs considerable shock and is subject to forces from walking, bending, and twisting. Pain can arise from several causes, including abnormal mobility in either direction, micro- or macro-fractures, ligament injury, inflammation, pregnancy-related changes, leg length differences, and degeneration after a prior lumbar spinal fusion.¹ The joint moves less than a millimeter in any direction, and research has found no clear difference in the amount of motion between healthy and dysfunctional joints, which helps explain why diagnosing the SI joint as the actual pain generator is notoriously tricky.²

How Doctors Confirm the SI Joint Is the Problem

SI joint pain often mimics lower-back or hip pain, and imaging alone rarely provides a definitive answer. Clinicians rely on a battery of hands-on provocation tests that stress the joint in specific ways. When three or more of these tests reproduce the patient’s familiar pain pattern, there is strong reason to suspect the SI joint: studies report sensitivity around 91 to 94 percent and specificity near 78 percent for correctly identifying SI joint pain when compared against the results of a diagnostic injection.³⁴ Conversely, when all six provocation tests fail to reproduce familiar pain, clinicians can confidently rule the SI joint out as the source.⁵

The five individual tests with the best track record in the research include the distraction test, compression test, thigh thrust (also called posterior shear), sacral thrust, and resisted hip abduction, each showing sensitivity and specificity above 60 percent on its own in at least one well-designed study.⁶ Because no single physical exam finding is definitive, diagnostic injections that numb the joint under image guidance have become the standard confirmation step before anyone considers surgery.

What Happens During the Surgery

The iFuse procedure is performed under general anesthesia with the patient lying face down. The surgeon makes a single incision roughly 3 to 5 centimeters long on the side of the buttock, then works through the gluteal muscle down to the outer surface of the ilium (the large wing of the pelvis). A guide pin is advanced through the ilium, across the SI joint, and into the sacrum, positioned carefully to avoid the nearby nerve openings. Imaging confirms pin placement, and the path is then drilled and broached to accept a triangular titanium implant. The triangular cross-section is a deliberate design choice: it resists rotation better than a cylindrical implant, which helps lock the joint in place immediately. Typically three implants are placed, two targeting the first sacral segment and one targeting the second.⁷ The implants have a porous titanium coating designed to encourage bone to grow into and around them over time, which is what turns a mechanical fixation into a true biological fusion.

Most patients go home the same day or after one night in the hospital. Weight-bearing with crutches or a walker is usually allowed immediately, though many surgeons restrict activities like heavy lifting and high-impact exercise for several weeks while early bone ingrowth takes hold.

How Well It Works in Controlled Trials

The strongest evidence for the iFuse procedure comes from prospective randomized controlled trials comparing surgery to continued non-surgical management. In one pivotal trial, the surgery group’s average pain score dropped from about 82 out of 100 at baseline to roughly 30 at six months, a 53-point improvement. The non-surgical group improved by only about 12 points over the same period. More than 81 percent of surgical patients met the study’s primary success endpoint at six months, compared with about 24 percent of non-surgical patients.⁸ Disability scores, measured by the Oswestry Disability Index, improved by about 30 points in the surgery group versus roughly 5 points in the non-surgical group.⁹

A separate European randomized trial echoed these findings, with back pain improving by about 43 points in the fusion group versus roughly 6 points in the conservative management group at six months, and disability improvements following a similar pattern.¹⁰ These are not modest gains; the differences between the surgery and non-surgery arms are among the largest seen in spine surgery trials.

Do the Results Last?

Short-term numbers are encouraging, but the question most patients care about is whether the improvement holds up years later. Two-year follow-up from one randomized trial showed a mean pain improvement of about 55 points in the surgery group, with more than 80 percent of patients reporting clinically meaningful benefit.¹¹ At a mean follow-up of nearly four years, pain scores held at about 2.6 out of 10, representing a roughly 5-point sustained drop on the standard pain scale, and disability scores remained improved.¹²

Five-year prospective data paint a similarly positive picture. Pain scores dropped by a mean of 54 points from baseline, disability improved by 26 points, and quality-of-life measures showed sustained gains. Radiographic analysis at five years found bone growing up to the implant surface on both sides of the joint in 98 percent of cases, with actual bony bridging across the joint in 87 percent and signs of loosening in only about 5 percent.¹³ The proportion of patients using opioid medication for SI joint pain dropped substantially over time. In the five-year data from that study, opioid use went from 77 percent at baseline to 41 percent.¹⁴ A separate five-year prospective trial using a newer 3D-printed version of the implant showed opioid use for SI joint pain falling from 57 percent at baseline to 17 percent at five years.¹⁵

Risks and Complications

An analysis of the manufacturer’s postmarket complaints database covering over 5,000 treated patients found that complaints of any kind were reported in about 3.8 percent. Pain was the most common issue, affecting roughly 2.2 percent. Nerve impingement occurred in about 0.9 percent of patients, and recurrent SI joint pain was reported in roughly 0.8 percent. All other individual complication types were rare, each occurring in 0.2 percent or fewer.¹⁶

Revision surgery was performed in about 1.8 percent of patients. Most revisions in the early postoperative period were for a symptomatic malpositioned implant, accounting for roughly 0.9 percent of cases. Late revisions were performed for symptom recurrence in about 0.6 percent. Wound infection, which can be a concern with any surgical implant, was reported in only about 0.15 percent of lateral triangular implant procedures in a large meta-analysis.¹⁷ These rates are low by the standards of spine surgery, though no procedure is risk-free.

Why Minimally Invasive Beats Open Surgery

Before the iFuse system and similar devices, SI joint fusion typically meant open surgery with large incisions, extensive muscle dissection, and prolonged hospital stays. Multicenter comparisons have shown that the minimally invasive approach results in significantly less blood loss, shorter operating time, shorter hospitalization, and substantially better pain relief. One comparison found that pain scores at 12 months were about 3 to 3.5 points lower (on a 10-point scale) in the minimally invasive group than in the open surgery group, even after matching for age, sex, and history of prior lumbar fusion.¹⁸ A separate comparative study confirmed greater improvement in disability scores with the minimally invasive approach along with shorter surgical time and hospital stay.¹⁹ At this point, open SI joint fusion has largely been replaced by minimally invasive techniques in practice.

Lateral vs. Posterior Approaches

The iFuse procedure uses a lateral approach, meaning implants enter from the side of the pelvis and cross the full width of the SI joint. Some newer devices take a posterior approach, entering from behind, while others use a posterolateral trajectory. A recent systematic review and meta-analysis compared pain and disability outcomes between the lateral and posterior approaches and found no meaningful difference in pain improvement, with both achieving roughly a 57 to 58 percent improvement in visual analog scale scores. The lateral approach showed somewhat better disability improvement on average (42 percent vs. 31 percent), though the difference was not statistically significant.²⁰

From a biomechanical standpoint, cadaver testing has found that both the lateral triangular implant design and a newer posterior transfixation cage system achieve comparable motion reduction across all planes. A posterolateral cylindrical threaded implant, by contrast, produced less motion reduction in certain directions. The posterior system removed less bone and introduced more implant surface to the joint space, which could theoretically promote faster bone growth, though clinical studies comparing long-term fusion rates head to head are still limited.²¹

Navigation and Robotic Assistance

Getting the implants positioned precisely is one of the keys to a good outcome and avoiding nerve irritation. Traditionally, surgeons relied on fluoroscopy (real-time X-ray) to guide placement. More recently, 3D navigation systems and even robotic assistance have been applied to SI joint fusion. The accuracy difference is substantial: one study comparing robotic to fluoroscopic implant placement found accuracy rates of about 98 percent versus 77 percent.²² A broader review of navigation and robotic systems reported accuracy rates in the 92 to 98 percent range compared with 76 to 87 percent for fluoroscopy alone, along with reductions in radiation exposure to the surgical team of up to 85 percent.²³ Given that symptomatic implant malposition is the most common reason for early revision surgery, improved accuracy is clinically meaningful, not just a technical nicety.

SI Joint Pain After Lumbar Fusion

One population that particularly benefits from awareness of this procedure is people who have already had lumbar spinal fusion. Fusing lumbar segments changes how the pelvis distributes load, and the SI joint often picks up extra stress as a result. Studies using diagnostic injections have confirmed that the SI joint is the cause of persistent or new-onset symptoms in a considerable proportion of patients after lumbar fusion.²⁴ One study found that about 12 percent of lumbar fusion patients developed new SI joint pain, with symptoms appearing an average of about 22 months after the original surgery.²⁵ For these patients, the iFuse procedure can address a pain source that is often misattributed to a failed lumbar fusion, potentially sparing them from unnecessary repeat lumbar surgery.

Postpartum Pelvic Pain

Pregnancy-related SI joint dysfunction is another situation where the procedure has been studied. Hormonal changes during pregnancy loosen the ligaments around the pelvis, and for some women, the resulting instability does not resolve after delivery. A multicenter prospective trial specifically evaluated women with persistent postpartum posterior pelvic girdle pain who had not responded to conservative treatment. At 12 months after minimally invasive SI joint fusion, these women reported a mean pain reduction of about 51 points on a 100-point scale, along with meaningful improvements in disability and quality-of-life measures. Their outcomes were comparable to those seen in the broader study population, suggesting the procedure works similarly regardless of how the SI joint dysfunction began.²⁶

What Happens to the Spine Above

A common worry with any fusion procedure is that locking one joint puts more stress on the segments next door. In SI joint fusion, the concern is whether fusing the pelvis might accelerate wear on the lowest lumbar disc at L5-S1. A finite element modeling study found that the increases in motion at L5-S1 after SI joint fusion were small: about 3 percent in flexion, 3.7 percent in extension, 1.1 percent in lateral bending, and 4.6 percent in axial rotation.²⁷ These are minor changes compared to what is seen with lumbar fusions, where adjacent-segment disease is a well-recognized long-term issue. The SI joint moves so little to begin with that eliminating its motion does not dramatically redistribute forces upward.

Cost and Value

Health-economic analyses have examined whether the procedure is worth the expense compared to ongoing non-surgical management. A U.S. cost-effectiveness study estimated that minimally invasive SI joint fusion produced about 0.74 additional quality-adjusted life years at a cost of roughly $13,300 per quality-adjusted life year gained, which falls well below the thresholds commonly used to judge a treatment as cost-effective. Looking further out, the analysis found that fusion potentially saved money compared to non-surgical management after about 13 years, because it reduced ongoing treatment costs like medications, physical therapy, and injections.²⁸ A similar analysis from the UK’s NHS perspective found even more favorable numbers, with a very high probability that fusion was cost-effective at standard willingness-to-pay thresholds.²⁹

When the Procedure Does Not Work

No surgical procedure succeeds every time. In the randomized trial data, roughly 15 to 20 percent of surgical patients did not meet the primary success endpoint at six months. Some failures stem from imprecise diagnosis: if the SI joint was not actually the main pain generator, fusing it will not help. Others involve technical issues like implant malposition, which as noted earlier accounts for most early revisions. A smaller group of patients achieves initial relief but then develops recurrent symptoms later, sometimes from failure of the bone to fully bridge across the joint, a condition called pseudoarthrosis.

For patients who do fail, revision options exist. A case series described a salvage technique where two variable-threaded screws were placed in a lateral-oblique trajectory around the existing implants, achieving a mean pain reduction from 9.5 to 1 on a 10-point scale and documented bone fusion on CT scans within six months.³⁰ That was a small series of three patients, so broad conclusions would be premature, but it illustrates that a failed initial fusion does not necessarily mean the joint cannot eventually be successfully stabilized.